Adam Spooner
Papers
1
Total Citations
9
H-Index
1
About
Adam Spooner is a rising analytical chemist whose work is sharpening the precision of therapeutic drug monitoring in psychiatry. His primary research focuses on developing robust liquid chromatography-tandem mass spectrometry (LC–MS/MS) methods for the quantification of pharmaceuticals in biological matrices, with a particular emphasis on antidepressants. Spooner’s most cited work, “An in-depth analysis of four classes of antidepressants quantification from human serum using LC–MS/MS” (2023, 9 citations), addresses a critical clinical bottleneck: the need for a single, reliable assay to monitor diverse antidepressant classes. By enabling simultaneous quantification of these drugs from serum, his method offers a practical tool for personalizing treatment regimens, potentially reducing the trial-and-error process that plagues depression management. This contribution is especially timely given the tripling of antidepressant prescriptions over the last two decades and the persistent challenge of matching patients to effective therapies. While early in his career, Spooner’s targeted approach to bioanalysis positions him at the intersection of analytical chemistry and clinical psychiatry, promising more efficient and personalized mental health care through precise, data-driven drug monitoring.
Research Focus
Key Achievements
Top Papers
- 1